855 related articles for article (PubMed ID: 19690471)
1. Human immunodeficiency virus and atherosclerosis.
Farrugia PM; Lucariello R; Coppola JT
Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
[TBL] [Abstract][Full Text] [Related]
2. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidaemia and cardiovascular risk in HIV infection.
Kulasekaram R; Peters BS; Wierzbicki AS
Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus.
Magen E; Elbirt D; Sthoeger Z
Isr Med Assoc J; 2005 Apr; 7(4):252-6. PubMed ID: 15847207
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
Boccara F
AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
[TBL] [Abstract][Full Text] [Related]
6. [Atherosclerosis in HIV-positive patients].
Neumann T; Miller M; Esser S; Gerken G; Erbel R
Z Kardiol; 2002 Nov; 91(11):879-88. PubMed ID: 12442190
[TBL] [Abstract][Full Text] [Related]
7. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
8. Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.
Fantoni M; Del Borgo C; Autore C; Barbaro G
Ital Heart J; 2002 May; 3(5):294-9. PubMed ID: 12066561
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease and toxicities related to HIV infection and its therapies.
Zareba KM; Miller TL; Lipshultz SE
Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
[TBL] [Abstract][Full Text] [Related]
10. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.
Venkat A; Piontkowsky DM; Cooney RR; Srivastava AK; Suares GA; Heidelberger CP
Ann Emerg Med; 2008 Sep; 52(3):274-85. PubMed ID: 18358567
[TBL] [Abstract][Full Text] [Related]
11. Vascular injury, hypertension and coronary artery disease in human immunodeficiency virus infection.
Barbaro G
Clin Ter; 2008; 159(1):51-5. PubMed ID: 18399263
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of HIV cardiac disease.
Cotter BR
Prog Cardiovasc Dis; 2003; 45(4):319-26. PubMed ID: 12638095
[TBL] [Abstract][Full Text] [Related]
13. Cerebrovascular disease in highly active antiretroviral therapy-treated individuals: incidence and risk factors.
Monforte Ad; Bongiovanni M
J Neurovirol; 2005; 11 Suppl 3():34-7. PubMed ID: 16540453
[TBL] [Abstract][Full Text] [Related]
14. [Guidelines for antiretroviral therapy of human immunodeficiency virus (HIV)-infected subjects in the Czech Republic].
Sedlácek D; Stanková M; Machala L; Rozsypal H; Snopková S; Dostál V; Kolcáková J; Dlouhý P; Jerhotová Z
Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):28-34. PubMed ID: 17417753
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
Grinspoon S; Carr A
N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
[No Abstract] [Full Text] [Related]
16. Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients.
Marfo K; Greenstein S
Transplant Proc; 2009 Nov; 41(9):3796-9. PubMed ID: 19917390
[TBL] [Abstract][Full Text] [Related]
17. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
Crook M
Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
[TBL] [Abstract][Full Text] [Related]
18. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.
Santoro-Lopes G; de Pinho AM; Harrison LH; Schechter M
Clin Infect Dis; 2002 Feb; 34(4):543-6. PubMed ID: 11797184
[TBL] [Abstract][Full Text] [Related]
19. C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s.
Henry K; Kitch D; Dube M; Zackin R; Parker RA; Sprecher D; Hammer S; Currier J;
AIDS; 2004 Dec; 18(18):2434-7. PubMed ID: 15622323
[No Abstract] [Full Text] [Related]
20. Perspective on HIV infection and aging: emerging research on the horizon.
Casau NC
Clin Infect Dis; 2005 Sep; 41(6):855-63. PubMed ID: 16107986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
